Trademark: 79046388
Word
ALBIREO
Status
Dead
Status Code
402
Status Date
Tuesday, November 7, 2017
Serial Number
79046388
Mark Type
4000
Filing Date
Tuesday, November 6, 2007
Abandoned Date
Tuesday, November 7, 2017

Trademark Owner History
Albireo AB c-o AstraZeneca AB, Legal Dept. - 1st New Owner Before Publication
José Luis Cabero - Original Applicant

Classifications
5 Pharmaceutical preparations for human use in the prevention and treatment of gynaecological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders, hepatico- pancreatico biliary- diseases, musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; skin and tissue repair and smoking cessation; Sanitary preparations for medical purposes; Veterinary pharmaceutical preparations for the prevention and treatment of gynaccological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; hepatico- pancreatico- biliary- diseases, musculoskeletal diseases and disorders; pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction, haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, gingivitis, halitosis and periodontal disease; skin and tissue repair; all of the foregoing for treating felines, canines, bovines, porcines, equines, llamas, rabbits, rodents, birds, ferrets, poultry, goats and sheep
10 Surgical, medical and veterinary apparatus and instruments, namely, upper gastrointestinal endoscopes/colonoscopes with stents, injection devices for intragastric/intrarectal injection/infusion, dilation balloons with drug delivery systems, targeted delivery devices to specific parts of the gastrointestinal tract using ingested capsules with remote control release mechanism
42 Scientific consulting services and research and design in the field of the development of pharmaceutical and medical preparations and products

Trademark Events
Jun 2, 2018
Notification Of Effect Of Abandonment Of Intl Reg E-Mailed
Jun 1, 2018
Death Of International Registration
Mar 22, 2013
New Representative At Ib Received
Jul 30, 2011
Final Decision Transaction Processed By Ib
Jul 11, 2011
Final Disposition Notice Sent To Ib
Jul 9, 2011
Final Disposition Notice Created, To Be Sent To Ib
Jul 9, 2010
Abandonment Notice Mailed - Failure To Respond
Jul 9, 2010
Abandonment - Failure To Respond Or Late Response
Dec 4, 2009
Notification Of Final Refusal Emailed
Dec 4, 2009
Final Refusal E-Mailed
Dec 4, 2009
Final Refusal Written
Sep 17, 2009
Notification Of Letter Of Suspension E-Mailed
Sep 17, 2009
Letter Of Suspension E-Mailed
Sep 17, 2009
Suspension Letter Written
Sep 16, 2009
Amendment From Applicant Entered
Sep 16, 2009
Correspondence Received In Law Office
Sep 11, 2009
Paper Received
Aug 6, 2009
Notification Of Possible Opposition - Processed By Ib
May 14, 2009
Notification Of Possible Opposition Sent To Ib
May 14, 2009
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 11, 2009
Notification Of Non-Final Action E-Mailed
Mar 11, 2009
Non-Final Action E-Mailed
Mar 11, 2009
Non-Final Action Written
Mar 3, 2009
Amendment From Applicant Entered
Mar 3, 2009
Correspondence Received In Law Office
Feb 27, 2009
Paper Received
Jan 14, 2009
Teas Change Of Correspondence Received
Dec 13, 2008
Change Of Name/Address Rec'd From Ib
Aug 27, 2008
Notification Of Non-Final Action E-Mailed
Aug 27, 2008
Non-Final Action E-Mailed
Aug 27, 2008
Non-Final Action Written
Aug 20, 2008
Amendment From Applicant Entered
Aug 20, 2008
Correspondence Received In Law Office
Aug 20, 2008
Assigned To Lie
Aug 14, 2008
Paper Received
Apr 10, 2008
Change Of Owner Received From Ib
Mar 14, 2008
Refusal Processed By Ib
Feb 23, 2008
Non-Final Action Mailed - Refusal Sent To Ib
Feb 22, 2008
Refusal Processed By Mpu
Feb 22, 2008
Non-Final Action (Ib Refusal) Prepared For Review
Feb 21, 2008
Non-Final Action Written
Feb 20, 2008
Assigned To Examiner
Dec 14, 2007
New Application Entered In Tram
Dec 13, 2007
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24